CompanyTrack
S

SPYBIOTECH LIMITED

Active Oxford

Research and experimental development on biotechnology

17 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
S

SPYBIOTECH LIMITED

Research and experimental development on biotechnology

Founded 2 Mar 2017 Active Oxford, United Kingdom 17 employees spybiotech.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 12 Nov 2025
Confirmation Statement Submitted 17 Mar 2025
Net assets £10.78M £5.20M 2023 year on year
Total assets £14.45M £4.09M 2023 year on year
Total Liabilities £3.67M £1.10M 2023 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

7600 The Quorum, Alec Issigonis Way Oxford Business Park North Oxford OX4 2JZ United Kingdom

Credit Report

Discover SPYBIOTECH LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2021–2023)

Cash in Bank

£12.17M

Decreased by £4.23M (-26%)

Net Assets

£10.78M

Decreased by £5.20M (-33%)

Total Liabilities

£3.67M

Increased by £1.10M (+43%)

Turnover

N/A

Employees

17

Increased by 2 (+13%)

Debt Ratio

25%

Increased by 11 (+79%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

12 Allotments 10,085,830 Shares £24.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Sept 2025104,315£70k£0.67
19 Nov 20243,784£113.52£0.03
26 Jun 202419,560£19.56£0.001
25 Jan 202478,245£78.245£0.001
25 Jan 20246,150£184.5£0.03

Officers

Officers

6 active 5 resigned
Status
Andre Crawford-bruntDirectorSouth AfricanEngland545 Feb 2021Active
Edward James GrayDirectorBritishEngland662 Feb 2023Active
Ekaterina SmirnyaginaDirectorFrenchUnited Kingdom598 Oct 2021Active
Mark LeuchtenbergerDirectorAmericanUnited States696 Jun 2022Active
Stuart ChaffeeDirectorAmericanUnited States5231 Jul 2025Active
Sumi BiswasDirectorBritishEngland4210 Mar 2017Active

Shareholders

Shareholders (21)

Uk Ff Nominees Ltd
12.0%
2,156,02714 Mar 2025
The Chancellor, Masters And Scholars Of The University Of Oxford
5.6%
1,000,00014 Mar 2025
Thompson Taraz Nominees Ltd
1.9%
333,33314 Mar 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Oxford Science Enterprises Plc

United Kingdom

Active
Notified 2 Mar 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

The Chancellor, Masters And Scholars Of The University Of Oxford

Ceased 2 Mar 2018

Ceased

Group Structure

Group Structure

SPYBIOTECH LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
6 Dec 2025OfficersTermination of Mark Leuchtenberger as director on 2025-11-26View(1 page)
12 Nov 2025AccountsAnnual accounts made up to 2024-12-31View(33 pages)
18 Sept 2025CapitalAllotment of shares (GBP 6,625.482) on 2025-09-10View(6 pages)
26 Aug 2025OfficersAppointment of Mr Stuart Chaffee as director on 2025-07-31View(2 pages)
6 Aug 2025OfficersTermination of Daniel Menichella as director on 2025-07-31View(1 page)
6 Dec 2025 Officers

Termination of Mark Leuchtenberger as director on 2025-11-26

12 Nov 2025 Accounts

Annual accounts made up to 2024-12-31

18 Sept 2025 Capital

Allotment of shares (GBP 6,625.482) on 2025-09-10

26 Aug 2025 Officers

Appointment of Mr Stuart Chaffee as director on 2025-07-31

6 Aug 2025 Officers

Termination of Daniel Menichella as director on 2025-07-31

Recent Activity

Latest Activity

Termination of Mark Leuchtenberger as director on 2025-11-26

2 months ago on 6 Dec 2025

Annual accounts made up to 2024-12-31

3 months ago on 12 Nov 2025

Allotment of shares (GBP 6,625.482) on 2025-09-10

5 months ago on 18 Sept 2025

Appointment of Mr Stuart Chaffee as director on 2025-07-31

5 months ago on 26 Aug 2025

Termination of Daniel Menichella as director on 2025-07-31

6 months ago on 6 Aug 2025